Sulforaphane Supplement in Gummy Form Patent Application
Summary
The USPTO has published a patent application (US20260083667A1) for a sulforaphane supplement in gummy form. The application, filed by Sensory Scout LLC, describes a composition including sulforaphane, glucoraphanin, and myrosinase immobilized within a gummy matrix. This represents a new patent filing for a novel supplement formulation.
What changed
The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083667A1, filed on September 26, 2025. The application, assigned to Sensory Scout LLC, details a sulforaphane supplement formulated in a gummy form. The core innovation lies in the composition, which includes sulforaphane, glucoraphanin, and myrosinase, with these active ingredients disposed and immobilized within the gummy matrix structure.
This publication signifies a new patent application for a specific dietary supplement formulation. While patent applications do not impose direct regulatory obligations on other entities, they indicate potential future product development and market entry in the supplement and pharmaceutical sectors. Companies involved in the development or manufacturing of dietary supplements, particularly those containing sulforaphane or similar compounds, should be aware of this filing as it may relate to intellectual property landscapes and competitive offerings in the market.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SULFORAPHANE SUPPLEMENT IN GUMMY FORM
Application US20260083667A1 Kind: A1 Mar 26, 2026
Assignee
Sensory Scout LLC
Inventors
Benzion Sadigursky
Abstract
A sulforaphane supplement in gummy form, including an active ingredient composition comprising sulforaphane, glucoraphanin, and myrosinase. The supplement including a matrix structure in which sulforaphane, glucoraphanin, and myrosinase are disposed in pores and immobilized therein.
CPC Classifications
A61K 9/0056 A61K 31/26 A61K 31/7028 A61K 36/31 A61K 38/47 A61K 47/12 A61K 47/26 A61K 47/36 C12Y 302/01147
Filing Date
2025-09-26
Application No.
19341677
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.